Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 8566 AL 8580

Preventing Alzheimer's disease and cognitive decline

Williams JW, Plassman BL, Burke J, Benjamin S.

Evid Rep Technol Assess (Full Rep). 2010 Apr;(193):1-727.

Lack of awareness of symptoms in people with dementia: the structural and functional basis

Zamboni G, Wilcock G.

Int J Geriatr Psychiatry. 2011 Aug;26(8):783-92. doi: 10.1002/gps.2620. Epub 2010 Oct 28.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.

Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.

[Language disorders in ALS/FTLD]

Ichikawa H.

Rinsho Shinkeigaku. 2010 Nov;50(11):1014-6. doi: 10.5692/clinicalneurol.50.1014.

Medicinal plants and dementia therapy: herbal hopes for brain aging?

Perry E, Howes MJ.

CNS Neurosci Ther. 2011 Dec;17(6):683-98. doi: 10.1111/j.1755-5949.2010.00202.x. Epub 2010 Oct 18.

Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease

Fiala M, Veerhuis R.

Exp Gerontol. 2010 Jan;45(1):57-63. doi: 10.1016/j.exger.2009.08.003. Epub 2009 Aug 21.

Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications

Ho L, Fivecoat H, Wang J, Pasinetti GM.

Exp Gerontol. 2010 Jan;45(1):15-22. doi: 10.1016/j.exger.2009.09.007. Epub 2009 Sep 29.

Origins, controversies and recent developments of the MCI construct

Gainotti G.

Curr Alzheimer Res. 2010 May;7(3):271-9. doi: 10.2174/156720510791050858.

Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls

von Känel R, Ancoli-Israel S, Dimsdale JE, Mills PJ, Mausbach BT, Ziegler MG, Patterson TL, Grant I.

Gerontology. 2010;56(1):41-50. doi: 10.1159/000264654. Epub 2009 Dec 3.

Genetic risk factors and candidate biomarkers for Alzheimer's disease

Scapagnini G, Caruso C, Vasto S, Pascale A, Romeo L, D'Agata V, Intrieri M, Sapere N, Li Volti G.

Front Biosci (Schol Ed). 2010 Jan 1;2(2):616-22. doi: 10.2741/s89.

Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease

Iuliano L, Monticolo R, Straface G, Spoletini I, Gianni W, Caltagirone C, Bossù P, Spalletta G.

J Alzheimers Dis. 2010;21(4):1383-92. doi: 10.3233/jad-2010-100780.

Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men

Chu LW, Tam S, Wong RL, Yik PY, Song Y, Cheung BM, Morley JE, Lam KS.

J Alzheimers Dis. 2010;21(4):1335-45. doi: 10.3233/jad-2010-100027.

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

Hertze J, Minthon L, Zetterberg H, Vanmechelen E, Blennow K, Hansson O.

J Alzheimers Dis. 2010;21(4):1119-28. doi: 10.3233/jad-2010-100207.

Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis

Xin XY, Ding JQ, Chen SD.

J Alzheimers Dis. 2010;19(4):1283-94. doi: 10.3233/JAD-2010-1329.

Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?

Krautwald M, Münch G.

Exp Gerontol. 2010 Oct;45(10):744-51. doi: 10.1016/j.exger.2010.03.001. Epub 2010 Mar 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias